SOPHARMA AD - Sales revenues for September 2018

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 120 / 2018

Date of issue: 2018-10-05

Short name of the issuer

SOPHARMA AD

Subject

Sales revenues for September 2018

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

Sopharma AD (the “Company”) notifies that for September 2018 the Company recorded decrease of sales revenues of 7% compared to the same month of 2017, including 55% increase of domestic sales and a decrease of 28% of export sales. Revenue in the third quarter of 2018 increases compared to the same period in 2017, respectively, by 5%, incl. 10% increase of sales for the domestic market and 2% increase in export sales. Successful work during the quarter contributes to reducing the rate of decline in revenue and for the first nine months of this year, revenues from sales of products decreased by 4% (8% as at 30.06.2018) compared to the same period of 2017, including 1% decrease of domestic sales and 6% decrease of export sales.

Annexes

File Description

Sales revenues for September 2018 espi.pdf Sales revenues for September 2018

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2018-10-05 Ognian Donev Executive director